Balance Sheet

Cash Flow Statement

Acquisitions Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Intangibles Change in Intangibles Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt issuances

Growth Metrics

Hypha Labs (FUNI) Change in Inventory (2019)

Hypha Labs filings provide 6 years of Change in Inventory readings, the most recent being $37900.0 for Q4 2019.

On a quarterly basis, Change in Inventory changed N/A to $37900.0 in Q4 2019 year-over-year; TTM through Sep 2020 was $37900.0, a N/A change, with the full-year FY2020 number at $37900.0, changed N/A from a year prior.
Change in Inventory hit $37900.0 in Q4 2019 for Hypha Labs, up from -$13578.0 in the prior quarter.
In the past five years, Change in Inventory ranged from a high of $37900.0 in Q4 2019 to a low of -$13578.0 in Q3 2015.